4 Funding Announcements Made By Payer/Employer Health Tech Startups in March
Here is a list of some of the biggest funding rounds in the payer/employer space that were announced this month.
EY: 65% of Healthcare Organizations Have Seen a Positive Return on Health Equity Efforts
A new report from Ernst & Young revealed that healthcare organizations are seeing financial benefits and improved outcomes from their health equity strategies.
presented by
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
We Need Your Self-Insured Employer Health Benefits Insights for Our Annual Survey
Do you advise self-insured employers? The 2023 Benefit Consultant Sentiment INDEX offered robust insights and cast a spotlight on the evolving roles of employers as they navigate the changing healthcare landscape. Your insights offer leading, innovative points of view that can guide employers and peers. Join us for this year's survey!
At ViVE 2024, Panelists Share Prior Authorization Progress and Frustration in Payer Insights Program
At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.
3 Reasons to Attend the Payer Insights Sessions at ViVE 2024
The Payer Insights Program at ViVE 2024, in partnership with MedCity News, kicks off day one at the event. This new immersive program will focus on the impact of rising healthcare costs, recent regulatory changes, and innovative payer solutions for optimizing data insights, minimizing costs, and expanding access to care.
ViVE 2024: Optimizing Provider and Payer Meetings
A preview of ViVE 2024 offers a sneak peek at the agenda and how the Payer and Provider Connect meeting platform initiatives have been revamped to maximize the quantity and quality of meeting for healthcare executives.
Health Benefit Consultants, Share Your Expert Insights in Our Survey
Share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health, healthcare navigation, and more.
KPMG: Tailwinds and Headwinds for Payers in 2024
A recent KPMG report laid out several tailwinds and headwinds for payers in 2024. Payers' tailwinds include reduced recession worries, while their headwinds include Medicare Advantage scrutiny.
Payer’s Place: Dr. Matthew Hurford, UPMC Health Plan
How UPMC Health Plan is taking steps in providing better behavioral health support.
Amazon Exec: We Love Innovation, But We Don’t Love to Talk About Who Pays for It
It’s easy to get caught up in the excitement surrounding innovations in the medical field, Amazon Pharmacy Chief Medical Officer Dr. Vin Gupta noted. But when talking about these innovations, healthcare leaders often fail to address questions about whether they will be covered by insurance and whether all patients will be able to benefit from them, he pointed out.
3 Tips That Could Reduce Friction in Payer-Provider Relationships
During a panel at MedCity News’ INVEST Digital Health conference, three executives representing a provider, a payer and a technology vendor shared their thoughts on how to heal the rocky relationship between hospitals and health plans. For instance, one leader encouraged payers and providers not to be afraid to give up some control, and another urged them to build comprehensive risk models.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Digital Medicines Sector Draws Lessons From Pear Therapeutics’ Demise
Digital therapeutics have shown how therapy can be delivered effectively through a digital interface, but the bankruptcy of Pear Therapeutics raised questions about whether these technologies can be commercially successful. A panel at the MedCity News INVEST Digital Health conference discussed the promise and pitfalls of these emerging technologies.
Payer’s Place: Shantanu Agrawal, MD, MPHIL, Elevance Health
Elevance Health is finding ways to connect with the community in order to achieve better health equity.
Payer Insights Program Highlights How Payers and Tech Partners Are Thinking About AI, Health Equity, and the Consumer Experience
HLTH 2023 introduced a new program focused on technology trends for and perspectives from payers in a series of conversations around AI, health equity and healthcare innovation.
Payer’s Place: Camille Harrison, GuideWell, Florida Blue
What does the future hold with AI and the healthcare ecosystem? Camille Harrison with GuideWell, Florida Blue joins the Payer's Place to share her thoughts.
Payer’s Place: Dawn Maroney, Alignment Health
CEO of Alignment Health joins the Payer's Place and details how the growth of Medicare Advantage will only help patients in the future.